Entheon Biomedical Ratios and Metrics

Market cap in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '25 Dec 18, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2019
Market Capitalization	1	1	1	2	32	31	Upgrade
Market Cap Growth	134.54%	109.89%	-66.67%	-94.44%	3.86%	-	Upgrade
Enterprise Value	1	1	0	2	28	29	Upgrade
Last Close Price	0.10	0.14	0.10	0.30	5.40	7.60	Upgrade
PS Ratio	-	-	2.36	9.35	-	-	Upgrade
PB Ratio	3.56	8.53	1.87	2.88	3.52	8.20	Upgrade
P/TBV Ratio	3.56	8.53	1.87	2.88	10.13	8.20	Upgrade
EV/Sales Ratio	-	-	0.84	8.04	-	-	Upgrade
Net Debt / Equity Ratio	-0.98	-0.94	-1.09	-1.11	-0.23	-0.76	Upgrade
Net Debt / EBITDA Ratio	-	-	-	0.19	0.25	1.73	Upgrade
Net Debt / FCF Ratio	1.10	0.38	0.96	0.35	0.38	1.00	Upgrade
Asset Turnover	-	-	0.43	0.04	-	-	Upgrade
Quick Ratio	21.16	3.54	4.11	4.67	2.24	4.00	Upgrade
Current Ratio	21.84	4.53	4.64	4.81	3.46	6.05	Upgrade
Return on Equity (ROE)	-110.91%	-137.90%	-64.49%	-42.66%	-125.03%	-231.39%	Upgrade
Return on Assets (ROA)	-67.20%	-70.93%	-33.41%	-41.88%	-71.06%	-44.49%	Upgrade
Return on Capital Employed (ROCE)	-90.80%	-228.90%	-99.10%	-585.80%	-90.80%	-43.80%	Upgrade
Earnings Yield	-24.74%	-25.63%	-50.77%	-480.67%	-27.87%	-14.27%	Upgrade
FCF Yield	-	-28.68%	-60.91%	-110.26%	-16.72%	-9.27%	Upgrade
Buyback Yield / Dilution	-73.57%	-30.96%	-	-8.85%	-97.83%	-543.78%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.